Literature DB >> 8593374

Incidence of pulmonary tuberculosis among diabetics.

S J Kim1, Y P Hong, W J Lew, S C Yang, E G Lee.   

Abstract

SETTING: Longitudinal epidemiological study based on diabetic and non-diabetic civil servants in Korea.
OBJECTIVE: To determine a comparative incidence of pulmonary tuberculosis (PTB) between diabetic and non-diabetic subjects.
DESIGN: Investigation of newly developed PTB among diabetics and non-diabetics between 1988 and 1990, on the basis of biennial medical examination and the medical records of those who claimed health insurance for tuberculosis.
RESULTS: The 1990 medical examination and investigation of medical records of the health insurance claimants revealed that PTB had developed in 170 patients (including 37 smear and eight culture positives) among 8015 diabetics, and in 4935 patients (including 538 smear and 342 culture positives) among 806,698 control subjects. Estimated annual incidence rates of PTB of (1) all types, (2) smear and/or culture positive versus (3) smear positive cases were 1061, 281 and 231 per 10(5) respectively among diabetics and 306, 55 and 33 per 10(5) among non-diabetic controls. PTB developed in 167 of 7695 male diabetics and in 3 of 320 female diabetics. The greater the age, the more diabetics were found.
CONCLUSION: Relative risks (RR) of developing PTB of all types and bacteriologically confirmed cases were 3.47 times and 5.15 times higher in the diabetics than in the matched controls. A greater RR was observed on those at the age of 30-49 than in those of 50 years or more.

Entities:  

Mesh:

Year:  1995        PMID: 8593374     DOI: 10.1016/0962-8479(95)90529-4

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  49 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people.

Authors:  Roland F Dyck; Helena Klomp; Darcy D Marciniuk; Leonard Tan; Mary Rose Stang; Heather A Ward; Vernon H Hoeppner
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 3.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

4.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

Review 5.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

6.  Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases.

Authors:  Blanca I Restrepo; Aulasa J Camerlin; Mohammad H Rahbar; Weiwei Wang; Mary A Restrepo; Izelda Zarate; Francisco Mora-Guzmán; Jesus G Crespo-Solis; Jessica Briggs; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Bull World Health Organ       Date:  2011-03-30       Impact factor: 9.408

7.  The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus.

Authors:  J E Stalenhoef; B Alisjahbana; E J Nelwan; J van der Ven-Jongekrijg; T H M Ottenhoff; J W M van der Meer; R H Nelwan; M G Netea; R van Crevel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-26       Impact factor: 3.267

8.  Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.

Authors:  Kelly E Dooley; Tania Tang; Jonathan E Golub; Susan E Dorman; Wendy Cronin
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

Review 9.  Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  James C Johnston; Neal C Shahidi; Mohsen Sadatsafavi; J Mark Fitzgerald
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.